Figure 2. Cumulative incidence of inhibitor development according to cumulative number of factor VIII exposure days for all inhibitors, high-titer, and low-titer inhibitors.
Figure 2

Cumulative incidence of inhibitor development according to cumulative number of factor VIII exposure days for all inhibitors, high-titer, and low-titer inhibitors.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal